A detailed history of Enterprise Financial Services Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Enterprise Financial Services Corp holds 2,687 shares of AZN stock, worth $240,217. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,687
Holding current value
$240,217
% of portfolio
0.11%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 15, 2025

BUY
$68.72 - $82.11 $184,650 - $220,629
2,687 New
2,687 $206,000
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $8,211 - $9,702
-152 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$55.56 - $60.79 $64,782 - $70,881
-1,166 Reduced 88.47%
152 $9,000
Q2 2021

Aug 16, 2021

BUY
$48.42 - $60.18 $290 - $361
6 Added 0.46%
1,318 $79,000
Q1 2021

May 13, 2021

BUY
$47.16 - $54.44 $8,394 - $9,690
178 Added 15.7%
1,312 $66,000
Q4 2020

Feb 12, 2021

BUY
$48.52 - $58.02 $679 - $812
14 Added 1.25%
1,134 $57,000
Q3 2020

Nov 13, 2020

SELL
$53.07 - $61.1 $9,287 - $10,692
-175 Reduced 13.51%
1,120 $61,000
Q2 2020

Aug 04, 2020

BUY
$43.1 - $55.31 $5,473 - $7,024
127 Added 10.87%
1,295 $68,000
Q1 2020

May 15, 2020

BUY
$37.79 - $51.33 $4,156 - $5,646
110 Added 10.4%
1,168 $52,000
Q3 2019

Oct 31, 2019

BUY
$40.12 - $45.47 $1,444 - $1,636
36 Added 3.52%
1,058 $47,000
Q1 2019

Apr 26, 2019

BUY
$35.49 - $43.02 $5,394 - $6,539
152 Added 17.47%
1,022 $41,000
Q2 2018

Jul 27, 2018

BUY
$34.55 - $37.05 $2,902 - $3,112
84 Added 10.69%
870 $31,000
Q1 2018

Apr 27, 2018

BUY
$32.97 - $36.63 $9,033 - $10,036
274 Added 53.52%
786 $27,000
Q3 2017

Oct 27, 2017

BUY
$28.96 - $34.0 $14,827 - $17,408
512
512 $17,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $277B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Enterprise Financial Services Corp Portfolio

Follow Enterprise Financial Services Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Financial Services Corp with notifications on news.